nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—ABCG2—lung cancer	0.182	0.54	CbGaD
Vismodegib—ALB—lung cancer	0.0794	0.235	CbGaD
Vismodegib—ABCB1—lung cancer	0.0757	0.225	CbGaD
Vismodegib—ORM1—Gefitinib—lung cancer	0.0416	0.09	CbGbCtD
Vismodegib—ABCG2—Topotecan—lung cancer	0.0278	0.0601	CbGbCtD
Vismodegib—ABCG2—Gefitinib—lung cancer	0.0254	0.055	CbGbCtD
Vismodegib—ABCG2—Teniposide—lung cancer	0.0246	0.0533	CbGbCtD
Vismodegib—ORM1—Erlotinib—lung cancer	0.0246	0.0532	CbGbCtD
Vismodegib—ALB—Gefitinib—lung cancer	0.0175	0.0379	CbGbCtD
Vismodegib—ABCG2—Erlotinib—lung cancer	0.015	0.0325	CbGbCtD
Vismodegib—ABCG2—Paclitaxel—lung cancer	0.0137	0.0297	CbGbCtD
Vismodegib—ABCG2—Irinotecan—lung cancer	0.0136	0.0293	CbGbCtD
Vismodegib—CYP2C19—Gefitinib—lung cancer	0.0113	0.0246	CbGbCtD
Vismodegib—ABCG2—Cisplatin—lung cancer	0.0111	0.0239	CbGbCtD
Vismodegib—CYP2C19—Teniposide—lung cancer	0.011	0.0238	CbGbCtD
Vismodegib—ABCG2—Etoposide—lung cancer	0.0109	0.0235	CbGbCtD
Vismodegib—ALB—Erlotinib—lung cancer	0.0103	0.0224	CbGbCtD
Vismodegib—ABCB1—Topotecan—lung cancer	0.01	0.0217	CbGbCtD
Vismodegib—ABCG2—Docetaxel—lung cancer	0.00994	0.0215	CbGbCtD
Vismodegib—CYP2C9—Gefitinib—lung cancer	0.00943	0.0204	CbGbCtD
Vismodegib—ALB—Irinotecan—lung cancer	0.00935	0.0202	CbGbCtD
Vismodegib—ABCB1—Gefitinib—lung cancer	0.00916	0.0198	CbGbCtD
Vismodegib—CYP2C9—Teniposide—lung cancer	0.00915	0.0198	CbGbCtD
Vismodegib—CYP2C8—Erlotinib—lung cancer	0.008	0.0173	CbGbCtD
Vismodegib—ABCG2—Doxorubicin—lung cancer	0.00741	0.016	CbGbCtD
Vismodegib—CYP2C8—Paclitaxel—lung cancer	0.00732	0.0158	CbGbCtD
Vismodegib—ABCG2—Methotrexate—lung cancer	0.00718	0.0155	CbGbCtD
Vismodegib—ABCB1—Vinorelbine—lung cancer	0.00705	0.0153	CbGbCtD
Vismodegib—CYP3A4—Topotecan—lung cancer	0.006	0.013	CbGbCtD
Vismodegib—CYP2C8—Etoposide—lung cancer	0.00579	0.0125	CbGbCtD
Vismodegib—ABCB1—Crizotinib—lung cancer	0.00561	0.0121	CbGbCtD
Vismodegib—CYP3A4—Gefitinib—lung cancer	0.00549	0.0119	CbGbCtD
Vismodegib—ABCB1—Gemcitabine—lung cancer	0.00549	0.0119	CbGbCtD
Vismodegib—ABCB1—Erlotinib—lung cancer	0.00541	0.0117	CbGbCtD
Vismodegib—CYP3A4—Teniposide—lung cancer	0.00532	0.0115	CbGbCtD
Vismodegib—CYP2C9—Paclitaxel—lung cancer	0.00511	0.0111	CbGbCtD
Vismodegib—ABCB1—Paclitaxel—lung cancer	0.00496	0.0107	CbGbCtD
Vismodegib—ALB—Methotrexate—lung cancer	0.00495	0.0107	CbGbCtD
Vismodegib—ABCB1—Irinotecan—lung cancer	0.00489	0.0106	CbGbCtD
Vismodegib—ABCB1—Vinblastine—lung cancer	0.00435	0.00941	CbGbCtD
Vismodegib—CYP3A4—Vinorelbine—lung cancer	0.00423	0.00915	CbGbCtD
Vismodegib—CYP2C9—Cisplatin—lung cancer	0.00411	0.00889	CbGbCtD
Vismodegib—ABCB1—Cisplatin—lung cancer	0.00399	0.00863	CbGbCtD
Vismodegib—ABCB1—Etoposide—lung cancer	0.00392	0.00847	CbGbCtD
Vismodegib—ABCB1—Docetaxel—lung cancer	0.00358	0.00775	CbGbCtD
Vismodegib—CYP3A4—Crizotinib—lung cancer	0.00336	0.00728	CbGbCtD
Vismodegib—CYP3A4—Erlotinib—lung cancer	0.00324	0.00702	CbGbCtD
Vismodegib—CYP3A4—Paclitaxel—lung cancer	0.00297	0.00643	CbGbCtD
Vismodegib—CYP3A4—Irinotecan—lung cancer	0.00293	0.00634	CbGbCtD
Vismodegib—SMO—mammary gland—lung cancer	0.00289	0.116	CbGeAlD
Vismodegib—SHH—respiratory system—lung cancer	0.00276	0.111	CbGeAlD
Vismodegib—ABCB1—Doxorubicin—lung cancer	0.00267	0.00578	CbGbCtD
Vismodegib—CYP3A4—Vinblastine—lung cancer	0.0026	0.00564	CbGbCtD
Vismodegib—ABCB1—Methotrexate—lung cancer	0.00259	0.0056	CbGbCtD
Vismodegib—CYP3A4—Etoposide—lung cancer	0.00235	0.00508	CbGbCtD
Vismodegib—SHH—epithelium—lung cancer	0.0023	0.0926	CbGeAlD
Vismodegib—CYP3A4—Docetaxel—lung cancer	0.00215	0.00465	CbGbCtD
Vismodegib—SMO—respiratory system—lung cancer	0.00193	0.0775	CbGeAlD
Vismodegib—SHH—bone marrow—lung cancer	0.00162	0.0649	CbGeAlD
Vismodegib—CYP3A4—Doxorubicin—lung cancer	0.0016	0.00346	CbGbCtD
Vismodegib—SMO—bronchus—lung cancer	0.00159	0.0638	CbGeAlD
Vismodegib—SHH—lung—lung cancer	0.00146	0.0588	CbGeAlD
Vismodegib—SMO—trachea—lung cancer	0.00142	0.0573	CbGeAlD
Vismodegib—SMO—cardiac atrium—lung cancer	0.00134	0.0538	CbGeAlD
Vismodegib—ALB—mammary gland—lung cancer	0.00111	0.0446	CbGeAlD
Vismodegib—SMO—lung—lung cancer	0.00102	0.0411	CbGeAlD
Vismodegib—CYP2C8—mammary gland—lung cancer	0.000779	0.0313	CbGeAlD
Vismodegib—SMO—lymph node—lung cancer	0.0007	0.0281	CbGeAlD
Vismodegib—CYP2C9—mammary gland—lung cancer	0.000692	0.0278	CbGeAlD
Vismodegib—Sorafenib—RAF1—lung cancer	0.000637	0.138	CrCbGaD
Vismodegib—Sorafenib—FGFR1—lung cancer	0.000627	0.136	CrCbGaD
Vismodegib—Sorafenib—FLT1—lung cancer	0.000599	0.13	CrCbGaD
Vismodegib—ORM1—bone marrow—lung cancer	0.000494	0.0198	CbGeAlD
Vismodegib—ORM1—lung—lung cancer	0.000447	0.018	CbGeAlD
Vismodegib—Sorafenib—BRAF—lung cancer	0.000442	0.0957	CrCbGaD
Vismodegib—Sorafenib—KDR—lung cancer	0.000376	0.0813	CrCbGaD
Vismodegib—Sorafenib—KIT—lung cancer	0.000355	0.0768	CrCbGaD
Vismodegib—Sorafenib—UGT1A1—lung cancer	0.000349	0.0756	CrCbGaD
Vismodegib—ORM1—lymph node—lung cancer	0.000306	0.0123	CbGeAlD
Vismodegib—ABCG2—bone marrow—lung cancer	0.000296	0.0119	CbGeAlD
Vismodegib—Etoricoxib—CYP2E1—lung cancer	0.00028	0.0607	CrCbGaD
Vismodegib—ALB—lymph node—lung cancer	0.000268	0.0108	CbGeAlD
Vismodegib—ABCG2—lung—lung cancer	0.000268	0.0108	CbGeAlD
Vismodegib—ABCB1—respiratory system—lung cancer	0.000249	0.01	CbGeAlD
Vismodegib—ABCB1—epithelium—lung cancer	0.000208	0.00836	CbGeAlD
Vismodegib—Sulfasalazine—ABCG2—lung cancer	0.000208	0.045	CrCbGaD
Vismodegib—Sorafenib—ABCG2—lung cancer	0.000196	0.0425	CrCbGaD
Vismodegib—Tolvaptan—ABCB1—lung cancer	0.000194	0.042	CrCbGaD
Vismodegib—Alopecia—Irinotecan—lung cancer	0.000184	0.00209	CcSEcCtD
Vismodegib—ABCB1—trachea—lung cancer	0.000184	0.00739	CbGeAlD
Vismodegib—ABCG2—lymph node—lung cancer	0.000183	0.00737	CbGeAlD
Vismodegib—Dyspepsia—Erlotinib—lung cancer	0.000183	0.00207	CcSEcCtD
Vismodegib—Decreased appetite—Topotecan—lung cancer	0.000183	0.00207	CcSEcCtD
Vismodegib—Musculoskeletal pain—Doxorubicin—lung cancer	0.000181	0.00206	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Topotecan—lung cancer	0.000181	0.00206	CcSEcCtD
Vismodegib—Fatigue—Topotecan—lung cancer	0.000181	0.00205	CcSEcCtD
Vismodegib—Decreased appetite—Erlotinib—lung cancer	0.000181	0.00205	CcSEcCtD
Vismodegib—Vomiting—Teniposide—lung cancer	0.00018	0.00204	CcSEcCtD
Vismodegib—Constipation—Topotecan—lung cancer	0.00018	0.00204	CcSEcCtD
Vismodegib—Pain—Topotecan—lung cancer	0.00018	0.00204	CcSEcCtD
Vismodegib—Alopecia—Gemcitabine—lung cancer	0.00018	0.00204	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Erlotinib—lung cancer	0.000179	0.00203	CcSEcCtD
Vismodegib—Phosphatase alkaline increased—Doxorubicin—lung cancer	0.000179	0.00203	CcSEcCtD
Vismodegib—Fatigue—Erlotinib—lung cancer	0.000179	0.00203	CcSEcCtD
Vismodegib—Rash—Teniposide—lung cancer	0.000179	0.00203	CcSEcCtD
Vismodegib—Dermatitis—Teniposide—lung cancer	0.000178	0.00202	CcSEcCtD
Vismodegib—Pain—Erlotinib—lung cancer	0.000178	0.00201	CcSEcCtD
Vismodegib—Constipation—Erlotinib—lung cancer	0.000178	0.00201	CcSEcCtD
Vismodegib—Gastrointestinal pain—Vinblastine—lung cancer	0.000177	0.002	CcSEcCtD
Vismodegib—Nervous system disorder—Vinorelbine—lung cancer	0.000176	0.002	CcSEcCtD
Vismodegib—Back pain—Irinotecan—lung cancer	0.000176	0.00199	CcSEcCtD
Vismodegib—Muscle spasms—Irinotecan—lung cancer	0.000175	0.00198	CcSEcCtD
Vismodegib—Skin disorder—Vinorelbine—lung cancer	0.000175	0.00198	CcSEcCtD
Vismodegib—Etoricoxib—PTGS2—lung cancer	0.000173	0.0374	CrCbGaD
Vismodegib—Gastrointestinal pain—Topotecan—lung cancer	0.000172	0.00195	CcSEcCtD
Vismodegib—Back pain—Gemcitabine—lung cancer	0.000171	0.00194	CcSEcCtD
Vismodegib—Abdominal pain—Vinblastine—lung cancer	0.000171	0.00194	CcSEcCtD
Vismodegib—Gastrointestinal pain—Erlotinib—lung cancer	0.00017	0.00193	CcSEcCtD
Vismodegib—Blood urea increased—Doxorubicin—lung cancer	0.000169	0.00192	CcSEcCtD
Vismodegib—Nausea—Teniposide—lung cancer	0.000168	0.00191	CcSEcCtD
Vismodegib—Alopecia—Cisplatin—lung cancer	0.000167	0.0019	CcSEcCtD
Vismodegib—Connective tissue disorder—Paclitaxel—lung cancer	0.000167	0.0019	CcSEcCtD
Vismodegib—Abdominal pain—Topotecan—lung cancer	0.000166	0.00188	CcSEcCtD
Vismodegib—Malnutrition—Cisplatin—lung cancer	0.000165	0.00187	CcSEcCtD
Vismodegib—Abdominal pain—Erlotinib—lung cancer	0.000164	0.00186	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000164	0.00186	CcSEcCtD
Vismodegib—Weight decreased—Docetaxel—lung cancer	0.000163	0.00185	CcSEcCtD
Vismodegib—Muscle spasms—Cisplatin—lung cancer	0.000158	0.0018	CcSEcCtD
Vismodegib—Decreased appetite—Vinorelbine—lung cancer	0.000156	0.00177	CcSEcCtD
Vismodegib—Asthenia—Vinblastine—lung cancer	0.000155	0.00176	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000155	0.00176	CcSEcCtD
Vismodegib—Fatigue—Vinorelbine—lung cancer	0.000155	0.00176	CcSEcCtD
Vismodegib—Pain—Vinorelbine—lung cancer	0.000154	0.00174	CcSEcCtD
Vismodegib—Constipation—Vinorelbine—lung cancer	0.000154	0.00174	CcSEcCtD
Vismodegib—Alopecia—Etoposide—lung cancer	0.000153	0.00174	CcSEcCtD
Vismodegib—Asthenia—Topotecan—lung cancer	0.000151	0.00171	CcSEcCtD
Vismodegib—Myalgia—Gemcitabine—lung cancer	0.000151	0.00171	CcSEcCtD
Vismodegib—Arthralgia—Gemcitabine—lung cancer	0.000151	0.00171	CcSEcCtD
Vismodegib—Alopecia—Paclitaxel—lung cancer	0.00015	0.0017	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Doxorubicin—lung cancer	0.00015	0.0017	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.00015	0.0017	CcSEcCtD
Vismodegib—Asthenia—Erlotinib—lung cancer	0.000149	0.00169	CcSEcCtD
Vismodegib—Pruritus—Topotecan—lung cancer	0.000149	0.00168	CcSEcCtD
Vismodegib—Malnutrition—Paclitaxel—lung cancer	0.000148	0.00168	CcSEcCtD
Vismodegib—Diarrhoea—Vinblastine—lung cancer	0.000148	0.00168	CcSEcCtD
Vismodegib—Dysgeusia—Etoposide—lung cancer	0.000148	0.00168	CcSEcCtD
Vismodegib—Pruritus—Erlotinib—lung cancer	0.000147	0.00167	CcSEcCtD
Vismodegib—Gastrointestinal pain—Vinorelbine—lung cancer	0.000147	0.00167	CcSEcCtD
Vismodegib—Back pain—Etoposide—lung cancer	0.000146	0.00166	CcSEcCtD
Vismodegib—ABCB1—bone marrow—lung cancer	0.000146	0.00586	CbGeAlD
Vismodegib—Nervous system disorder—Irinotecan—lung cancer	0.000145	0.00165	CcSEcCtD
Vismodegib—Muscle spasms—Etoposide—lung cancer	0.000145	0.00165	CcSEcCtD
Vismodegib—Dysgeusia—Paclitaxel—lung cancer	0.000145	0.00164	CcSEcCtD
Vismodegib—Diarrhoea—Topotecan—lung cancer	0.000144	0.00163	CcSEcCtD
Vismodegib—Back pain—Paclitaxel—lung cancer	0.000143	0.00162	CcSEcCtD
Vismodegib—Muscle spasms—Paclitaxel—lung cancer	0.000142	0.00161	CcSEcCtD
Vismodegib—Diarrhoea—Erlotinib—lung cancer	0.000142	0.00161	CcSEcCtD
Vismodegib—Abdominal pain—Vinorelbine—lung cancer	0.000142	0.00161	CcSEcCtD
Vismodegib—Connective tissue disorder—Docetaxel—lung cancer	0.000142	0.00161	CcSEcCtD
Vismodegib—Nervous system disorder—Gemcitabine—lung cancer	0.000142	0.0016	CcSEcCtD
Vismodegib—Myalgia—Cisplatin—lung cancer	0.00014	0.00159	CcSEcCtD
Vismodegib—Skin disorder—Gemcitabine—lung cancer	0.00014	0.00159	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000139	0.00158	CcSEcCtD
Vismodegib—Vomiting—Vinblastine—lung cancer	0.000137	0.00156	CcSEcCtD
Vismodegib—Breast disorder—Methotrexate—lung cancer	0.000136	0.00154	CcSEcCtD
Vismodegib—Vomiting—Topotecan—lung cancer	0.000134	0.00151	CcSEcCtD
Vismodegib—Rash—Topotecan—lung cancer	0.000132	0.0015	CcSEcCtD
Vismodegib—Dermatitis—Topotecan—lung cancer	0.000132	0.0015	CcSEcCtD
Vismodegib—ABCB1—lung—lung cancer	0.000132	0.00531	CbGeAlD
Vismodegib—Vomiting—Erlotinib—lung cancer	0.000132	0.0015	CcSEcCtD
Vismodegib—Nervous system disorder—Cisplatin—lung cancer	0.000132	0.0015	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000131	0.00149	CcSEcCtD
Vismodegib—Rash—Erlotinib—lung cancer	0.000131	0.00149	CcSEcCtD
Vismodegib—Dermatitis—Erlotinib—lung cancer	0.000131	0.00148	CcSEcCtD
Vismodegib—Skin disorder—Cisplatin—lung cancer	0.000131	0.00148	CcSEcCtD
Vismodegib—Hyponatraemia—Doxorubicin—lung cancer	0.000131	0.00148	CcSEcCtD
Vismodegib—Dyspepsia—Irinotecan—lung cancer	0.00013	0.00148	CcSEcCtD
Vismodegib—Pain in extremity—Doxorubicin—lung cancer	0.00013	0.00147	CcSEcCtD
Vismodegib—Asthenia—Vinorelbine—lung cancer	0.000129	0.00146	CcSEcCtD
Vismodegib—Decreased appetite—Irinotecan—lung cancer	0.000129	0.00146	CcSEcCtD
Vismodegib—Nausea—Vinblastine—lung cancer	0.000128	0.00146	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Irinotecan—lung cancer	0.000128	0.00145	CcSEcCtD
Vismodegib—Fatigue—Irinotecan—lung cancer	0.000128	0.00145	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000128	0.00145	CcSEcCtD
Vismodegib—Alopecia—Docetaxel—lung cancer	0.000127	0.00144	CcSEcCtD
Vismodegib—Pruritus—Vinorelbine—lung cancer	0.000127	0.00144	CcSEcCtD
Vismodegib—Pain—Irinotecan—lung cancer	0.000127	0.00144	CcSEcCtD
Vismodegib—Constipation—Irinotecan—lung cancer	0.000127	0.00144	CcSEcCtD
Vismodegib—Myalgia—Paclitaxel—lung cancer	0.000126	0.00143	CcSEcCtD
Vismodegib—Arthralgia—Paclitaxel—lung cancer	0.000126	0.00143	CcSEcCtD
Vismodegib—Malnutrition—Docetaxel—lung cancer	0.000126	0.00142	CcSEcCtD
Vismodegib—Decreased appetite—Gemcitabine—lung cancer	0.000125	0.00142	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000125	0.00142	CcSEcCtD
Vismodegib—Nausea—Topotecan—lung cancer	0.000125	0.00141	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000125	0.00141	CcSEcCtD
Vismodegib—Fatigue—Gemcitabine—lung cancer	0.000124	0.00141	CcSEcCtD
Vismodegib—Pain—Gemcitabine—lung cancer	0.000123	0.0014	CcSEcCtD
Vismodegib—Constipation—Gemcitabine—lung cancer	0.000123	0.0014	CcSEcCtD
Vismodegib—Nausea—Erlotinib—lung cancer	0.000123	0.0014	CcSEcCtD
Vismodegib—Diarrhoea—Vinorelbine—lung cancer	0.000123	0.00139	CcSEcCtD
Vismodegib—Dysgeusia—Docetaxel—lung cancer	0.000123	0.00139	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000123	0.00139	CcSEcCtD
Vismodegib—Back pain—Docetaxel—lung cancer	0.000121	0.00138	CcSEcCtD
Vismodegib—Gastrointestinal pain—Irinotecan—lung cancer	0.000121	0.00137	CcSEcCtD
Vismodegib—Dehydration—Doxorubicin—lung cancer	0.000121	0.00137	CcSEcCtD
Vismodegib—Muscle spasms—Docetaxel—lung cancer	0.000121	0.00137	CcSEcCtD
Vismodegib—Skin disorder—Etoposide—lung cancer	0.00012	0.00136	CcSEcCtD
Vismodegib—Abdominal pain upper—Doxorubicin—lung cancer	0.000119	0.00135	CcSEcCtD
Vismodegib—Nervous system disorder—Paclitaxel—lung cancer	0.000119	0.00134	CcSEcCtD
Vismodegib—Hypokalaemia—Doxorubicin—lung cancer	0.000118	0.00134	CcSEcCtD
Vismodegib—Breast disorder—Doxorubicin—lung cancer	0.000118	0.00133	CcSEcCtD
Vismodegib—Skin disorder—Paclitaxel—lung cancer	0.000117	0.00133	CcSEcCtD
Vismodegib—Abdominal pain—Irinotecan—lung cancer	0.000117	0.00133	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000117	0.00133	CcSEcCtD
Vismodegib—Decreased appetite—Cisplatin—lung cancer	0.000117	0.00133	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Cisplatin—lung cancer	0.000116	0.00132	CcSEcCtD
Vismodegib—Pain—Cisplatin—lung cancer	0.000115	0.0013	CcSEcCtD
Vismodegib—Vomiting—Vinorelbine—lung cancer	0.000114	0.0013	CcSEcCtD
Vismodegib—Rash—Vinorelbine—lung cancer	0.000113	0.00128	CcSEcCtD
Vismodegib—Dermatitis—Vinorelbine—lung cancer	0.000113	0.00128	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00011	0.00125	CcSEcCtD
Vismodegib—Decreased appetite—Etoposide—lung cancer	0.000107	0.00121	CcSEcCtD
Vismodegib—Myalgia—Docetaxel—lung cancer	0.000107	0.00121	CcSEcCtD
Vismodegib—Arthralgia—Docetaxel—lung cancer	0.000107	0.00121	CcSEcCtD
Vismodegib—Nausea—Vinorelbine—lung cancer	0.000107	0.00121	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Etoposide—lung cancer	0.000106	0.00121	CcSEcCtD
Vismodegib—Dyspepsia—Paclitaxel—lung cancer	0.000106	0.00121	CcSEcCtD
Vismodegib—Asthenia—Irinotecan—lung cancer	0.000106	0.00121	CcSEcCtD
Vismodegib—Fatigue—Etoposide—lung cancer	0.000106	0.0012	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000106	0.0012	CcSEcCtD
Vismodegib—Pain—Etoposide—lung cancer	0.000105	0.0012	CcSEcCtD
Vismodegib—Constipation—Etoposide—lung cancer	0.000105	0.0012	CcSEcCtD
Vismodegib—Decreased appetite—Paclitaxel—lung cancer	0.000105	0.00119	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000104	0.00118	CcSEcCtD
Vismodegib—Fatigue—Paclitaxel—lung cancer	0.000104	0.00118	CcSEcCtD
Vismodegib—Asthenia—Gemcitabine—lung cancer	0.000104	0.00117	CcSEcCtD
Vismodegib—Pain—Paclitaxel—lung cancer	0.000103	0.00117	CcSEcCtD
Vismodegib—Constipation—Paclitaxel—lung cancer	0.000103	0.00117	CcSEcCtD
Vismodegib—Pruritus—Gemcitabine—lung cancer	0.000102	0.00116	CcSEcCtD
Vismodegib—Sulfasalazine—PTGS2—lung cancer	0.000102	0.022	CrCbGaD
Vismodegib—Weight decreased—Doxorubicin—lung cancer	0.000102	0.00115	CcSEcCtD
Vismodegib—Diarrhoea—Irinotecan—lung cancer	0.000101	0.00115	CcSEcCtD
Vismodegib—Gastrointestinal pain—Etoposide—lung cancer	0.000101	0.00114	CcSEcCtD
Vismodegib—Nervous system disorder—Docetaxel—lung cancer	0.0001	0.00114	CcSEcCtD
Vismodegib—Skin disorder—Docetaxel—lung cancer	9.95e-05	0.00113	CcSEcCtD
Vismodegib—Gastrointestinal pain—Paclitaxel—lung cancer	9.88e-05	0.00112	CcSEcCtD
Vismodegib—Diarrhoea—Gemcitabine—lung cancer	9.88e-05	0.00112	CcSEcCtD
Vismodegib—Abdominal pain—Etoposide—lung cancer	9.74e-05	0.0011	CcSEcCtD
Vismodegib—Asthenia—Cisplatin—lung cancer	9.65e-05	0.00109	CcSEcCtD
Vismodegib—Abdominal pain—Paclitaxel—lung cancer	9.55e-05	0.00108	CcSEcCtD
Vismodegib—Vomiting—Irinotecan—lung cancer	9.42e-05	0.00107	CcSEcCtD
Vismodegib—Rash—Irinotecan—lung cancer	9.34e-05	0.00106	CcSEcCtD
Vismodegib—Dermatitis—Irinotecan—lung cancer	9.33e-05	0.00106	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Docetaxel—lung cancer	9.33e-05	0.00106	CcSEcCtD
Vismodegib—Diarrhoea—Cisplatin—lung cancer	9.2e-05	0.00104	CcSEcCtD
Vismodegib—Alopecia—Methotrexate—lung cancer	9.18e-05	0.00104	CcSEcCtD
Vismodegib—Vomiting—Gemcitabine—lung cancer	9.18e-05	0.00104	CcSEcCtD
Vismodegib—Rash—Gemcitabine—lung cancer	9.1e-05	0.00103	CcSEcCtD
Vismodegib—Dermatitis—Gemcitabine—lung cancer	9.09e-05	0.00103	CcSEcCtD
Vismodegib—Malnutrition—Methotrexate—lung cancer	9.05e-05	0.00103	CcSEcCtD
Vismodegib—ABCB1—lymph node—lung cancer	9.04e-05	0.00363	CbGeAlD
Vismodegib—Dyspepsia—Docetaxel—lung cancer	9.02e-05	0.00102	CcSEcCtD
Vismodegib—Decreased appetite—Docetaxel—lung cancer	8.9e-05	0.00101	CcSEcCtD
Vismodegib—Dysgeusia—Methotrexate—lung cancer	8.86e-05	0.001	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Docetaxel—lung cancer	8.84e-05	0.001	CcSEcCtD
Vismodegib—Asthenia—Etoposide—lung cancer	8.84e-05	0.001	CcSEcCtD
Vismodegib—Connective tissue disorder—Doxorubicin—lung cancer	8.84e-05	0.001	CcSEcCtD
Vismodegib—Fatigue—Docetaxel—lung cancer	8.83e-05	0.001	CcSEcCtD
Vismodegib—Nausea—Irinotecan—lung cancer	8.8e-05	0.000998	CcSEcCtD
Vismodegib—Constipation—Docetaxel—lung cancer	8.76e-05	0.000993	CcSEcCtD
Vismodegib—Pain—Docetaxel—lung cancer	8.76e-05	0.000993	CcSEcCtD
Vismodegib—Back pain—Methotrexate—lung cancer	8.75e-05	0.000992	CcSEcCtD
Vismodegib—Pruritus—Etoposide—lung cancer	8.72e-05	0.000989	CcSEcCtD
Vismodegib—Asthenia—Paclitaxel—lung cancer	8.67e-05	0.000983	CcSEcCtD
Vismodegib—Nausea—Gemcitabine—lung cancer	8.57e-05	0.000972	CcSEcCtD
Vismodegib—Vomiting—Cisplatin—lung cancer	8.55e-05	0.00097	CcSEcCtD
Vismodegib—Pruritus—Paclitaxel—lung cancer	8.55e-05	0.000969	CcSEcCtD
Vismodegib—Rash—Cisplatin—lung cancer	8.48e-05	0.000962	CcSEcCtD
Vismodegib—Dermatitis—Cisplatin—lung cancer	8.47e-05	0.000961	CcSEcCtD
Vismodegib—Diarrhoea—Etoposide—lung cancer	8.43e-05	0.000956	CcSEcCtD
Vismodegib—Gastrointestinal pain—Docetaxel—lung cancer	8.38e-05	0.00095	CcSEcCtD
Vismodegib—Diarrhoea—Paclitaxel—lung cancer	8.27e-05	0.000938	CcSEcCtD
Vismodegib—Sorafenib—ABCB1—lung cancer	8.17e-05	0.0177	CrCbGaD
Vismodegib—Abdominal pain—Docetaxel—lung cancer	8.1e-05	0.000918	CcSEcCtD
Vismodegib—Nausea—Cisplatin—lung cancer	7.99e-05	0.000906	CcSEcCtD
Vismodegib—Alopecia—Doxorubicin—lung cancer	7.95e-05	0.000902	CcSEcCtD
Vismodegib—Vomiting—Etoposide—lung cancer	7.84e-05	0.000889	CcSEcCtD
Vismodegib—Malnutrition—Doxorubicin—lung cancer	7.83e-05	0.000888	CcSEcCtD
Vismodegib—Rash—Etoposide—lung cancer	7.77e-05	0.000881	CcSEcCtD
Vismodegib—Dermatitis—Etoposide—lung cancer	7.76e-05	0.00088	CcSEcCtD
Vismodegib—Arthralgia—Methotrexate—lung cancer	7.7e-05	0.000873	CcSEcCtD
Vismodegib—Myalgia—Methotrexate—lung cancer	7.7e-05	0.000873	CcSEcCtD
Vismodegib—Vomiting—Paclitaxel—lung cancer	7.68e-05	0.000871	CcSEcCtD
Vismodegib—Dysgeusia—Doxorubicin—lung cancer	7.67e-05	0.00087	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.65e-05	0.000867	CcSEcCtD
Vismodegib—Rash—Paclitaxel—lung cancer	7.62e-05	0.000864	CcSEcCtD
Vismodegib—Dermatitis—Paclitaxel—lung cancer	7.61e-05	0.000863	CcSEcCtD
Vismodegib—Back pain—Doxorubicin—lung cancer	7.58e-05	0.000859	CcSEcCtD
Vismodegib—Muscle spasms—Doxorubicin—lung cancer	7.53e-05	0.000854	CcSEcCtD
Vismodegib—Asthenia—Docetaxel—lung cancer	7.35e-05	0.000833	CcSEcCtD
Vismodegib—Nausea—Etoposide—lung cancer	7.32e-05	0.00083	CcSEcCtD
Vismodegib—Pruritus—Docetaxel—lung cancer	7.25e-05	0.000822	CcSEcCtD
Vismodegib—Nervous system disorder—Methotrexate—lung cancer	7.24e-05	0.000821	CcSEcCtD
Vismodegib—Nausea—Paclitaxel—lung cancer	7.18e-05	0.000814	CcSEcCtD
Vismodegib—Skin disorder—Methotrexate—lung cancer	7.17e-05	0.000813	CcSEcCtD
Vismodegib—Diarrhoea—Docetaxel—lung cancer	7.01e-05	0.000795	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Methotrexate—lung cancer	6.73e-05	0.000763	CcSEcCtD
Vismodegib—Arthralgia—Doxorubicin—lung cancer	6.67e-05	0.000756	CcSEcCtD
Vismodegib—Myalgia—Doxorubicin—lung cancer	6.67e-05	0.000756	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.62e-05	0.000751	CcSEcCtD
Vismodegib—Vomiting—Docetaxel—lung cancer	6.51e-05	0.000738	CcSEcCtD
Vismodegib—Dyspepsia—Methotrexate—lung cancer	6.5e-05	0.000737	CcSEcCtD
Vismodegib—Rash—Docetaxel—lung cancer	6.46e-05	0.000732	CcSEcCtD
Vismodegib—Dermatitis—Docetaxel—lung cancer	6.45e-05	0.000732	CcSEcCtD
Vismodegib—Decreased appetite—Methotrexate—lung cancer	6.42e-05	0.000728	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Methotrexate—lung cancer	6.37e-05	0.000723	CcSEcCtD
Vismodegib—Fatigue—Methotrexate—lung cancer	6.36e-05	0.000722	CcSEcCtD
Vismodegib—Pain—Methotrexate—lung cancer	6.31e-05	0.000716	CcSEcCtD
Vismodegib—Nervous system disorder—Doxorubicin—lung cancer	6.27e-05	0.000711	CcSEcCtD
Vismodegib—Skin disorder—Doxorubicin—lung cancer	6.21e-05	0.000704	CcSEcCtD
Vismodegib—Nausea—Docetaxel—lung cancer	6.08e-05	0.00069	CcSEcCtD
Vismodegib—Gastrointestinal pain—Methotrexate—lung cancer	6.04e-05	0.000684	CcSEcCtD
Vismodegib—Abdominal pain—Methotrexate—lung cancer	5.84e-05	0.000662	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.82e-05	0.00066	CcSEcCtD
Vismodegib—Dyspepsia—Doxorubicin—lung cancer	5.63e-05	0.000638	CcSEcCtD
Vismodegib—Decreased appetite—Doxorubicin—lung cancer	5.56e-05	0.00063	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Doxorubicin—lung cancer	5.52e-05	0.000626	CcSEcCtD
Vismodegib—Fatigue—Doxorubicin—lung cancer	5.51e-05	0.000625	CcSEcCtD
Vismodegib—Constipation—Doxorubicin—lung cancer	5.47e-05	0.00062	CcSEcCtD
Vismodegib—Pain—Doxorubicin—lung cancer	5.47e-05	0.00062	CcSEcCtD
Vismodegib—Asthenia—Methotrexate—lung cancer	5.3e-05	0.000601	CcSEcCtD
Vismodegib—Gastrointestinal pain—Doxorubicin—lung cancer	5.23e-05	0.000593	CcSEcCtD
Vismodegib—Pruritus—Methotrexate—lung cancer	5.22e-05	0.000592	CcSEcCtD
Vismodegib—Abdominal pain—Doxorubicin—lung cancer	5.05e-05	0.000573	CcSEcCtD
Vismodegib—Diarrhoea—Methotrexate—lung cancer	5.05e-05	0.000573	CcSEcCtD
Vismodegib—Vomiting—Methotrexate—lung cancer	4.69e-05	0.000532	CcSEcCtD
Vismodegib—Rash—Methotrexate—lung cancer	4.65e-05	0.000528	CcSEcCtD
Vismodegib—Dermatitis—Methotrexate—lung cancer	4.65e-05	0.000527	CcSEcCtD
Vismodegib—Asthenia—Doxorubicin—lung cancer	4.59e-05	0.00052	CcSEcCtD
Vismodegib—Pruritus—Doxorubicin—lung cancer	4.52e-05	0.000513	CcSEcCtD
Vismodegib—Nausea—Methotrexate—lung cancer	4.39e-05	0.000497	CcSEcCtD
Vismodegib—Diarrhoea—Doxorubicin—lung cancer	4.37e-05	0.000496	CcSEcCtD
Vismodegib—Vomiting—Doxorubicin—lung cancer	4.06e-05	0.000461	CcSEcCtD
Vismodegib—Rash—Doxorubicin—lung cancer	4.03e-05	0.000457	CcSEcCtD
Vismodegib—Dermatitis—Doxorubicin—lung cancer	4.03e-05	0.000457	CcSEcCtD
Vismodegib—Nausea—Doxorubicin—lung cancer	3.8e-05	0.000431	CcSEcCtD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	5.44e-06	6.54e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NCOA3—lung cancer	5.41e-06	6.51e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ADCY1—lung cancer	5.4e-06	6.49e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ABCG2—lung cancer	5.4e-06	6.49e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ENO1—lung cancer	5.39e-06	6.48e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.37e-06	6.45e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ENO1—lung cancer	5.36e-06	6.44e-05	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	5.35e-06	6.43e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.34e-06	6.42e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.3e-06	6.37e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ENO2—lung cancer	5.29e-06	6.36e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—HPGDS—lung cancer	5.29e-06	6.36e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ADCY1—lung cancer	5.27e-06	6.33e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ABCG2—lung cancer	5.27e-06	6.33e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PPP2R1B—lung cancer	5.26e-06	6.32e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP2A7—lung cancer	5.25e-06	6.31e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—RAF1—lung cancer	5.23e-06	6.29e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALDOA—lung cancer	5.21e-06	6.26e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.19e-06	6.24e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—HPGDS—lung cancer	5.17e-06	6.21e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ENO2—lung cancer	5.17e-06	6.21e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SDC4—lung cancer	5.14e-06	6.18e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PPP2R1B—lung cancer	5.13e-06	6.17e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTT1—lung cancer	5.13e-06	6.17e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PIK3CB—lung cancer	5.11e-06	6.14e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GCLC—lung cancer	5.07e-06	6.1e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP2A6—lung cancer	5.07e-06	6.1e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NCOA3—lung cancer	5.06e-06	6.08e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.05e-06	6.07e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTT1—lung cancer	5.01e-06	6.02e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.97e-06	5.97e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP2A6—lung cancer	4.95e-06	5.95e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GCLC—lung cancer	4.95e-06	5.95e-05	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	4.94e-06	5.93e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ADCY1—lung cancer	4.92e-06	5.91e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ABCG2—lung cancer	4.92e-06	5.91e-05	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	4.86e-06	5.84e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP2E1—lung cancer	4.83e-06	5.81e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—HPGDS—lung cancer	4.83e-06	5.8e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ENO2—lung cancer	4.83e-06	5.8e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ENO1—lung cancer	4.81e-06	5.78e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP2E1—lung cancer	4.81e-06	5.78e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—APOA1—lung cancer	4.8e-06	5.77e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PPP2R1B—lung cancer	4.8e-06	5.76e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.79e-06	5.76e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—NQO1—lung cancer	4.78e-06	5.74e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—NQO1—lung cancer	4.75e-06	5.71e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.73e-06	5.69e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.73e-06	5.69e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ENO1—lung cancer	4.69e-06	5.64e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IL2—lung cancer	4.69e-06	5.64e-05	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	4.69e-06	5.64e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—RRM1—lung cancer	4.68e-06	5.63e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTA3—lung cancer	4.68e-06	5.63e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTT1—lung cancer	4.68e-06	5.62e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.68e-06	5.62e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.65e-06	5.59e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.64e-06	5.57e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GCLC—lung cancer	4.63e-06	5.56e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP2A6—lung cancer	4.63e-06	5.56e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.61e-06	5.54e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.61e-06	5.54e-05	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	4.53e-06	5.45e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—B4GALT5—lung cancer	4.4e-06	5.29e-05	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	4.39e-06	5.28e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ENO1—lung cancer	4.39e-06	5.27e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CG—lung cancer	4.38e-06	5.27e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.37e-06	5.25e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP2E1—lung cancer	4.31e-06	5.18e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.31e-06	5.18e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—STK11—lung cancer	4.31e-06	5.18e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—STK11—lung cancer	4.28e-06	5.15e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTA4—lung cancer	4.28e-06	5.15e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NQO1—lung cancer	4.27e-06	5.13e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—EP300—lung cancer	4.21e-06	5.06e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP2E1—lung cancer	4.21e-06	5.06e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.18e-06	5.02e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTA2—lung cancer	4.17e-06	5.01e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—POMC—lung cancer	4.17e-06	5.01e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NQO1—lung cancer	4.16e-06	5e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.14e-06	4.97e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SRC—lung cancer	4.1e-06	4.92e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CREBBP—lung cancer	4.06e-06	4.88e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.04e-06	4.86e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTA1—lung cancer	4.03e-06	4.84e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.02e-06	4.83e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VEGFA—lung cancer	3.99e-06	4.79e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTP1—lung cancer	3.99e-06	4.79e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCC3—lung cancer	3.98e-06	4.78e-05	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	3.97e-06	4.77e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTP1—lung cancer	3.96e-06	4.76e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—NRAS—lung cancer	3.94e-06	4.74e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP2E1—lung cancer	3.93e-06	4.73e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NQO1—lung cancer	3.89e-06	4.67e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CAT—lung cancer	3.88e-06	4.66e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CAT—lung cancer	3.86e-06	4.63e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.86e-06	4.63e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AKR1C1—lung cancer	3.86e-06	4.63e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CD—lung cancer	3.85e-06	4.63e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—STK11—lung cancer	3.85e-06	4.62e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.83e-06	4.61e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.81e-06	4.58e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ALB—lung cancer	3.8e-06	4.57e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.77e-06	4.54e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—MAPK3—lung cancer	3.77e-06	4.54e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ABCB1—lung cancer	3.77e-06	4.53e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—STK11—lung cancer	3.75e-06	4.51e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ABCB1—lung cancer	3.75e-06	4.51e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—UGT1A1—lung cancer	3.74e-06	4.5e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—TYMS—lung cancer	3.71e-06	4.45e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—TYMS—lung cancer	3.68e-06	4.43e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTM1—lung cancer	3.66e-06	4.4e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTM1—lung cancer	3.64e-06	4.38e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.61e-06	4.34e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GNG11—lung cancer	3.61e-06	4.34e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTP1—lung cancer	3.56e-06	4.28e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—STK11—lung cancer	3.51e-06	4.21e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTP1—lung cancer	3.47e-06	4.17e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP1A1—lung cancer	3.47e-06	4.17e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CAT—lung cancer	3.46e-06	4.16e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP1A1—lung cancer	3.45e-06	4.15e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ERCC2—lung cancer	3.44e-06	4.14e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.44e-06	4.14e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALDOA—lung cancer	3.44e-06	4.13e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ERCC2—lung cancer	3.42e-06	4.12e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—KRAS—lung cancer	3.39e-06	4.08e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CAT—lung cancer	3.38e-06	4.06e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ABCB1—lung cancer	3.37e-06	4.05e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CB—lung cancer	3.36e-06	4.04e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NCOA3—lung cancer	3.34e-06	4.01e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTGS2—lung cancer	3.33e-06	4e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TYMS—lung cancer	3.31e-06	3.98e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.29e-06	3.96e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTM1—lung cancer	3.27e-06	3.93e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ADCY1—lung cancer	3.25e-06	3.9e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCG2—lung cancer	3.25e-06	3.9e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTP1—lung cancer	3.24e-06	3.9e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TYMS—lung cancer	3.23e-06	3.88e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTM1—lung cancer	3.19e-06	3.84e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ENO2—lung cancer	3.18e-06	3.82e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—HPGDS—lung cancer	3.18e-06	3.82e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.16e-06	3.8e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CAT—lung cancer	3.16e-06	3.79e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.14e-06	3.77e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PIK3CA—lung cancer	3.12e-06	3.74e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP1A1—lung cancer	3.1e-06	3.72e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTT1—lung cancer	3.09e-06	3.71e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ERCC2—lung cancer	3.07e-06	3.69e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ABCB1—lung cancer	3.07e-06	3.69e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GCLC—lung cancer	3.05e-06	3.67e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP2A6—lung cancer	3.05e-06	3.67e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP1A1—lung cancer	3.03e-06	3.64e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TYMS—lung cancer	3.02e-06	3.62e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TP53—lung cancer	3.01e-06	3.62e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ERCC2—lung cancer	3e-06	3.61e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTM1—lung cancer	2.98e-06	3.58e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—APOA1—lung cancer	2.98e-06	3.58e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—APOA1—lung cancer	2.96e-06	3.56e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTEN—lung cancer	2.9e-06	3.49e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ENO1—lung cancer	2.89e-06	3.48e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—HRAS—lung cancer	2.88e-06	3.46e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.85e-06	3.43e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.84e-06	3.41e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP1A1—lung cancer	2.83e-06	3.4e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ERCC2—lung cancer	2.8e-06	3.37e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—EP300—lung cancer	2.77e-06	3.33e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CG—lung cancer	2.72e-06	3.27e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CG—lung cancer	2.7e-06	3.25e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—APOA1—lung cancer	2.66e-06	3.2e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—APOA1—lung cancer	2.6e-06	3.12e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP2E1—lung cancer	2.59e-06	3.12e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—POMC—lung cancer	2.59e-06	3.11e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—POMC—lung cancer	2.57e-06	3.09e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NQO1—lung cancer	2.57e-06	3.08e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.55e-06	3.06e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—AKT1—lung cancer	2.55e-06	3.06e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CREBBP—lung cancer	2.52e-06	3.03e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CREBBP—lung cancer	2.51e-06	3.01e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CG—lung cancer	2.43e-06	2.92e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—APOA1—lung cancer	2.42e-06	2.91e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CD—lung cancer	2.39e-06	2.87e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CD—lung cancer	2.38e-06	2.86e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CG—lung cancer	2.37e-06	2.85e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ALB—lung cancer	2.36e-06	2.84e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.32e-06	2.79e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—STK11—lung cancer	2.31e-06	2.78e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—POMC—lung cancer	2.31e-06	2.78e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—POMC—lung cancer	2.26e-06	2.71e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CREBBP—lung cancer	2.25e-06	2.71e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CG—lung cancer	2.21e-06	2.66e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CREBBP—lung cancer	2.2e-06	2.64e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTP1—lung cancer	2.14e-06	2.57e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CD—lung cancer	2.13e-06	2.56e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—POMC—lung cancer	2.11e-06	2.53e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ALB—lung cancer	2.11e-06	2.53e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CB—lung cancer	2.08e-06	2.5e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CD—lung cancer	2.08e-06	2.5e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CAT—lung cancer	2.08e-06	2.5e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CB—lung cancer	2.07e-06	2.49e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTGS2—lung cancer	2.06e-06	2.48e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ALB—lung cancer	2.06e-06	2.47e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTGS2—lung cancer	2.05e-06	2.47e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CREBBP—lung cancer	2.05e-06	2.47e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CA—lung cancer	2.05e-06	2.46e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCB1—lung cancer	2.03e-06	2.43e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TYMS—lung cancer	1.99e-06	2.39e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTM1—lung cancer	1.97e-06	2.36e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CD—lung cancer	1.95e-06	2.34e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ALB—lung cancer	1.92e-06	2.31e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP1A1—lung cancer	1.86e-06	2.24e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CB—lung cancer	1.86e-06	2.24e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ERCC2—lung cancer	1.85e-06	2.22e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTGS2—lung cancer	1.84e-06	2.22e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CB—lung cancer	1.82e-06	2.18e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTEN—lung cancer	1.8e-06	2.16e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTGS2—lung cancer	1.8e-06	2.16e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTEN—lung cancer	1.79e-06	2.15e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—EP300—lung cancer	1.72e-06	2.06e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—EP300—lung cancer	1.71e-06	2.05e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CB—lung cancer	1.7e-06	2.04e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS2—lung cancer	1.68e-06	2.02e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—AKT1—lung cancer	1.67e-06	2.01e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTEN—lung cancer	1.61e-06	1.93e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APOA1—lung cancer	1.6e-06	1.92e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTEN—lung cancer	1.57e-06	1.89e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—EP300—lung cancer	1.53e-06	1.84e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—EP300—lung cancer	1.5e-06	1.8e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTEN—lung cancer	1.47e-06	1.76e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CG—lung cancer	1.46e-06	1.75e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—EP300—lung cancer	1.4e-06	1.68e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—POMC—lung cancer	1.39e-06	1.67e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CREBBP—lung cancer	1.35e-06	1.63e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CD—lung cancer	1.28e-06	1.54e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CA—lung cancer	1.27e-06	1.53e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ALB—lung cancer	1.27e-06	1.52e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CA—lung cancer	1.26e-06	1.52e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CA—lung cancer	1.13e-06	1.36e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CB—lung cancer	1.12e-06	1.34e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS2—lung cancer	1.11e-06	1.33e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CA—lung cancer	1.11e-06	1.33e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AKT1—lung cancer	1.04e-06	1.25e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CA—lung cancer	1.03e-06	1.24e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AKT1—lung cancer	1.03e-06	1.24e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTEN—lung cancer	9.67e-07	1.16e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AKT1—lung cancer	9.26e-07	1.11e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—EP300—lung cancer	9.22e-07	1.11e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AKT1—lung cancer	9.04e-07	1.09e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AKT1—lung cancer	8.45e-07	1.02e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CA—lung cancer	6.82e-07	8.2e-06	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AKT1—lung cancer	5.57e-07	6.69e-06	CbGpPWpGaD
